Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells

INTRODUCTION: Cancer stem cells (CSCs) drive the initiation, maintenance, and therapy response of breast tumors. CD49f is expressed in breast CSCs and functions in the maintenance of stemness. Thus, blockade of CD49f is a potential therapeutic approach for targeting breast CSCs. In the present stu...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Drug Des Devel Ther
Prif Awduron: Velázquez-Quesada, Inés, Ruiz-Moreno, Angel J, Casique-Aguirre, Diana, Aguirre-Alvarado, Charmina, Cortés-Mendoza, Fabiola, de la Fuente-Granada, Marisol, García-Pérez, Carlos, Pérez-Tapia, Sonia M, González-Arenas, Aliesha, Segura-Cabrera, Aldo, Velasco-Velázquez, Marco A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove 2020
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7229803/
https://ncbi.nlm.nih.gov/pubmed/32494122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S247730
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg